Company overview
Bramble Energy develops Printed Circuit Board Fuel Cell (PCBFC™) technology, offering scalable, low-cost hydrogen fuel cells with industry-leading power density of 8.76 kW/L for reliable zero-emission power. These modular, customizable solutions support off-grid or hybrid energy needs in pharmaceutical facilities and R&D, accelerating decarbonization through manufacturable clean energy platforms. Their PCB-X™ technology enables global production using established supply chains, targeting costs as low as $60-100 per kW.
Bramble Energy is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include hydrogen fuel cells, pcbfc technology, clean energy pharma, scalable fuel cells, zero emission power.
Structured facts
- Website
- https://www.brambleenergy.com
- Markets served
- United States & Americas
- Keywords
- hydrogen fuel cells, pcbfc technology, clean energy pharma, scalable fuel cells, zero emission power
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What fuel cell capabilities does Bramble Energy offer for pharmaceutical applications?
- Bramble provides PCBFC™ hydrogen fuel cells with 8.76 kW/L power density, modular stacks for custom voltage, long energy life, low maintenance, and scalability for backup power or off-grid use in labs and facilities.
- What are the cost and manufacturing advantages of their technology?
- Using printed circuit board manufacturing, Bramble achieves low-cost production targeting $60-100 per kW, with rapid iteration, global scalability, and gigawatt supply capacity via established supply chains.
- What geographies do they serve and any regulatory notes?
- UK-based with global manufacturing accessibility for PCB-X™ solutions; focused on clean energy standards for Net Zero, partnering with entities like BOC and MAHLE, no specific pharma regulations noted but suitable for sustainable energy compliance.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
